On the Mechanism of Accumulation of Cholestanol in the Brain of Mice with a Disruption of Sterol 27-hydroxylase

Overview

Journal J Lipid Res

Publisher Elsevier

Specialty Biochemistry

Date 2010 Jun 1

PMID 20511491

Citations 33

Authors

Ann Bavner

Marjan Shafaati

Magnus Hansson

Maria Olin

Shoshi Shpitzen

Vardiella Meiner

Eran Leitersdorf

Ingemar Bjorkhem

Affiliations

Soon will be listed here.

Abstract

The rare disease cerebrotendinous xanthomatosis (CTX) is due to a lack of sterol 27-hydroxylase (CYP27A1) and is characterized by cholestanol-containing xanthomas in brain and tendons. Mice with the same defect do not develop xanthomas. The driving force in the development of the xanthomas is likely to be conversion of a bile acid precursor into cholestanol. The mechanism behind the xanthomas in the brain has not been clarified. We demonstrate here that female cyp27a1(-/-) mice have an increase of cholestanol of about 2.5- fold in plasma, 6-fold in tendons, and 12-fold in brain. Treatment of cyp27a1(-/-) mice with 0.05% cholic acid normalized the cholestanol levels in tendons and plasma and reduced the content in the brain. The above changes occurred in parallel with changes in plasma levels of 7alpha-hydroxy-4-cholesten-3-one, a precursor both to bile acids and cholestanol. Injection of a cyp27a1(-/-) mouse with (2)H(7)-labeled 7alpha-hydroxy-4-cholesten-3-one resulted in a significant incorporation of (2)H(7)-cholestanol in the brain. The results are consistent with a concentration-dependent flux of 7alpha-hydroxy-4-cholesten-3-one across the blood-brain barrier in cyp27a1(-/-) mice and subsequent formation of cholestanol. It is suggested that the same mechanism is responsible for accumulation of cholestanol in the brain of patients with CTX.

Citing Articles

Molecular Biological Mechanisms of Action of Chrysophanol in Hepatic Stellate Cells Activated by Hepatic B Virus X Based on Network Pharmacology.

Lin C, Cheng C, Chiou Y, Wang I, Kuo C Intervirology. 2024; 67(1):119-135.

PMID: 39647471 PMC: 11623962. DOI: 10.1159/000542355.

Impaired astrocytic synaptic function by peripheral cholesterol metabolite 27-hydroxycholesterol.

Spanos F, Gerenu G, Goikolea J, Latorre-Leal M, Balleza-Tapia H, Gomez K Front Cell Neurosci. 2024; 18:1347535.

PMID: 38650656 PMC: 11034371. DOI: 10.3389/fncel.2024.1347535.

Peripheral Vascular Disease and Carotid Artery Disease Are Associated with Decreased Bile Acid Excretion.

Charach L, Charach G, Karniel E, Galin L, Bar Ziv D, Grossman L Bioengineering (Basel). 2023; 10(8).

PMID: 37627820 PMC: 10451290. DOI: 10.3390/bioengineering10080935.

Quantitative characterizations of the cholesterol-related pathways in the retina and brain of hamsters.

Mast N, El-Darzi N, Li Y, Pikuleva I J Lipid Res. 2023; 64(7):100401.

PMID: 37330011 PMC: 10394389. DOI: 10.1016/j.jlr.2023.100401.

Roles of bile acids signaling in neuromodulation under physiological and pathological conditions.

Xing C, Huang X, Wang D, Yu D, Hou S, Cui H Cell Biosci. 2023; 13(1):106.

PMID: 37308953 PMC: 10258966. DOI: 10.1186/s13578-023-01053-z.

References

von Bahr S, Movin T, Papadogiannakis N, Pikuleva I, Ronnow P, Diczfalusy U . Mechanism of accumulation of cholesterol and cholestanol in tendons and the role of sterol 27-hydroxylase (CYP27A1). Arterioscler Thromb Vasc Biol. 2002; 22(7):1129-35. DOI: 10.1161/01.atv.0000022600.61391.a5. View

Goodwin B, Gauthier K, Umetani M, Watson M, Lochansky M, Collins J . Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor. Proc Natl Acad Sci U S A. 2003; 100(1):223-8. PMC: 140933. DOI: 10.1073/pnas.0237082100. View

Rosen H, Reshef A, Maeda N, Lippoldt A, Shpizen S, Triger L . Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene. J Biol Chem. 1998; 273(24):14805-12. DOI: 10.1074/jbc.273.24.14805. View

Dubrac S, Lear S, Ananthanarayanan M, Balasubramaniyan N, Bollineni J, Shefer S . Role of CYP27A in cholesterol and bile acid metabolism. J Lipid Res. 2004; 46(1):76-85. DOI: 10.1194/jlr.M400219-JLR200. View

Byun D, Kasama T, Shimizu T, Yorifuji H, Seyama Y . Effect of cholestanol feeding on sterol concentrations in the serum, liver, and cerebellum of mice. J Biochem. 1988; 103(2):375-9. DOI: 10.1093/oxfordjournals.jbchem.a122277. View

Hylemon P, Harder J . Biotransformation of monoterpenes, bile acids, and other isoprenoids in anaerobic ecosystems. FEMS Microbiol Rev. 1999; 22(5):475-88. DOI: 10.1111/j.1574-6976.1998.tb00382.x. View

Skrede S, Bjorkhem I, Buchmann M, Hopen G, Fausa O . A novel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated C27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis. J Clin Invest. 1985; 75(2):448-55. PMC: 423517. DOI: 10.1172/JCI111719. View

Folch J, ASCOLI I, Lees M, MEATH J, LeBARON N . Preparation of lipide extracts from brain tissue. J Biol Chem. 1951; 191(2):833-41. View

BERGINER V, Salen G, SHEFER S . Cerebrotendinous xanthomatosis. Neurol Clin. 1989; 7(1):55-74. View

10.

Acimovic J, Lovgren-Sandblom A, Monostory K, Rozman D, Golicnik M, Lutjohann D . Combined gas chromatographic/mass spectrometric analysis of cholesterol precursors and plant sterols in cultured cells. J Chromatogr B Analyt Technol Biomed Life Sci. 2009; 877(22):2081-6. DOI: 10.1016/j.jchromb.2009.05.050. View

11.

Babiker A, Andersson O, Lund E, Xiu R, Deeb S, Reshef A . Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport. J Biol Chem. 1997; 272(42):26253-61. DOI: 10.1074/jbc.272.42.26253. View

12.

Salen G, Grundy S . The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis. J Clin Invest. 1973; 52(11):2822-35. PMC: 302550. DOI: 10.1172/JCI107478. View

13.

Caligiuri G, Nicoletti A, Zhou X, Tornberg I, Hansson G . Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice. Atherosclerosis. 1999; 145(2):301-8. DOI: 10.1016/s0021-9150(99)00081-7. View

14.

Russell D . The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem. 2003; 72:137-74. DOI: 10.1146/annurev.biochem.72.121801.161712. View

15.

Paigen B, Morrow A, Holmes P, Mitchell D, Williams R . Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 1987; 68(3):231-40. DOI: 10.1016/0021-9150(87)90202-4. View

16.

Honda A, Salen G, Matsuzaki Y, Batta A, Xu G, Leitersdorf E . Side chain hydroxylations in bile acid biosynthesis catalyzed by CYP3A are markedly up-regulated in Cyp27-/- mice but not in cerebrotendinous xanthomatosis. J Biol Chem. 2001; 276(37):34579-85. DOI: 10.1074/jbc.M103025200. View

17.

Bjorkhem I, Karlmar K . Biosynthesis of cholestanol: conversion of cholesterol into 4-cholesten-3-one by rat liver microsomes. Biochim Biophys Acta. 1974; 337(1):129-31. DOI: 10.1016/0005-2760(74)90046-0. View

18.

Panzenboeck U, Andersson U, Hansson M, Sattler W, Meaney S, Bjorkhem I . On the mechanism of cerebral accumulation of cholestanol in patients with cerebrotendinous xanthomatosis. J Lipid Res. 2007; 48(5):1167-74. DOI: 10.1194/jlr.M700027-JLR200. View

19.

Heverin M, Meaney S, Brafman A, Shafir M, Olin M, Shafaati M . Studies on the cholesterol-free mouse: strong activation of LXR-regulated hepatic genes when replacing cholesterol with desmosterol. Arterioscler Thromb Vasc Biol. 2007; 27(10):2191-7. DOI: 10.1161/ATVBAHA.107.149823. View

20.

Folch J, Lees M, SLOANE STANLEY G . A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957; 226(1):497-509. View